As part of the implementation of the One Big Beautiful Bill Act (H.R. 1), the RISE (Reimaging and Improving Student Education) Negotiated Rulemaking Committee was established to implement certain higher education provisions for the Department of Education (DOE). One of the Committee’s charges was to propose a definition of “professional degree” programs that are eligible for higher student loan limits. The Committee reached consensus on the DOE’s new proposal in late November 2025.
While Pharmacy (PharmD) and Medicine (MD) were included on the list of professional degrees, many health professions were left off this list. Nursing, physician assistant, physical therapy, and occupational therapy, will now be categorized as “graduate degree” programs. Among other student loan changes, starting July 1, 2026, professional degree students will be eligible for lifetime loan limits of $200,000, while graduate degree students are capped at $100,000.
Although the official text of the proposed rule that would put these changes into effect won’t be released until later this month, HOPA has concerns with the proposed language and loan limits. Access to financial support for students is critical to maintaining a strong workforce. Any limitations put in place to restrict access to education will directly contribute to the growing shortage of healthcare workers in America.
Oncology care is a multi-disciplinary effort, where physicians, pharmacists, nurses, and other affiliated health professionals work together to provide the best possible care for patients. This collaborative effort can only continue if there is an adequate pipeline of dedicated and highly trained healthcare professionals ready to meet patient needs.
HOPA stands united with our nursing and health professional colleagues in opposing these proposed rule changes. We will continue to monitor this situation and advocate for adequate financing opportunities for health care education programs.
Learn more by visiting Congress.gov
